ArticleFrontiers in immunology2016

Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features.

Paulina A García-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.